Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Socioeconomic aspects of incretin-based therapy
doi:10.1530/eje.0.1390552 Falutz J, Mamputu JC, Potvin D, et al
Patient safety considerations include the potential for injection site reactions when administering multiple subcutaneous injections, particularly if proper site rotation is not maintained
Call 999 immediately for life-threatening symptoms such as anaphylaxis, severe chest pain, or signs of sepsis
No destinado a usarse como frmaco, aditivo alimentario, cosmtico o producto qumico domstico
US$ 21.95
US$ 25.38
US$ 23.71
US$ 29.41
US$ 29.60
